To evaluate the prognostic value of MVP in PAAD, we stratified the TCGA-PAAD cohort into MVP high- and low- expression groups, and performed Kaplan-Meier (KM) survival curve analysis of overall survival (OS), which revealed that the elevated expression of MVP was a prognostic indicator associated with a markedly poor prognosis. The gene discussed is MVP; the disease is pancreatic adenocarcinoma.